Search clinical trials for: Advagraf, pharmacogenetics, Cyp3A5
Total 36 results
-
Ziqiang LiActive, not recruitingComplete and Accurate Statistical Data of 60 Patients | CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately | Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients | According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the... and other conditionsChina
-
Inje UniversityCompletedHealthy Subjects | Pharmacokinetics of Three PDE5Is | Genetic Polymorphic CYP3A5
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Mahidol UniversityAstellas Pharma IncUnknown
-
Indiana UniversityThe National Center for Complementary and Integrative HealthRecruitingKidney Disease, Chronic | CBD | Transplant ComplicationUnited States
-
Unity Health TorontoCompletedReal Function Post Conversion From Prograf to Advagraf | Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversionCanada
-
Inje UniversityCompleted
-
The Second Artillery General HospitalCapital Medical University; Shanghai Changzheng Hospital; Air Force General Hospital... and other collaboratorsCompletedRenal TransplantationChina
-
Khon Kaen UniversityNational Science and Technology Development Agency, ThailandUnknownKidney TransplantationThailand
-
Singapore General HospitalActive, not recruitingKidney Transplant Rejection | Kidney Transplant; ComplicationsSingapore
-
Chulalongkorn UniversityUnknownKidney Transplantation RecipientsThailand
-
ViiV HealthcarePfizerCompleted
-
Rennes University HospitalCompleted
-
University of TurkuTurku University Hospital; Sanofi; Vaasa Central Hospital, Vaasa, Finland; medbase...CompletedCYP3A Phenotyping | CYP3A5 and MDR1 Genotyping | Docetaxel Toxicity | Associations Between Genetic Data and Docetaxel ToxicityFinland
-
Helwan UniversityAin Shams UniversityCompletedRenal TransplantationEgypt
-
PfizerCompleted
-
Seoul National University HospitalUnknownLiver DysfunctionKorea, Republic of
-
Rennes University HospitalCompleted
-
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina, Chapel HillCompleted
-
University of CincinnatiUniversity of Colorado, Denver; Children's Hospital Medical Center, CincinnatiCompletedComplication of TransplantUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedRenal Replacement TherapiesFrance
-
LI YANCompleted
-
Children's Cancer and Leukaemia GroupUnknownCYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With IfosfamideSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Chemotherapeutic Agent ToxicityIreland, United Kingdom
-
University of Oslo School of PharmacyCompleted
-
National Science Centre, PolandMedical University of WarsawRecruitingKidney Transplant Rejection | Liver Transplant; Complications | Immunosuppression | Metabolism Medication Toxicity | Genetic Predisposition | Kidney Transplant; Complications | Liver Transplant RejectionPoland
-
National Taiwan University HospitalUnknownLiver Transplantation | Kidney TransplantationTaiwan
-
KU LeuvenCompleted
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Institute of Liver and Biliary Sciences, IndiaRecruiting
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
AstraZenecaCompletedHealthy Volunteers | Pharmacologic ActionUnited States
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedLiver Transplant RecipientBelgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedImmunosuppression After Liver TransplantationFrance
-
Astellas Pharma IncCompletedLiver TransplantationUnited States
-
Astellas Pharma IncCompletedLiver TransplantationUnited States